Gerald Norman Wogan - Publications

Affiliations: 
Biological Engineering Massachusetts Institute of Technology, Cambridge, MA, United States 
Area:
cancer causation, with the long-range objective of contributing to the scientific foundation for preventive strategies
Website:
http://web.mit.edu/gnwlab/people/wogan.htm

157 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Erkekoglu P, Chao MW, Tseng CY, Engelward BP, Kose O, Kocer-Gumusel B, Wogan GN, Tannenbaum SR. Antioxidants and selenocompounds inhibit 3,5-dimethylaminophenol toxicity to human urothelial cells. Arhiv Za Higijenu Rada I Toksikologiju. 70: 18-29. PMID 30956221 DOI: 10.2478/Aiht-2019-70-3159  0.364
2017 Fedeles BI, Chawanthayatham S, Croy RG, Wogan GN, Essigmann JM. Early detection of the aflatoxin B1 mutational fingerprint: A diagnostic tool for liver cancer. Molecular & Cellular Oncology. 4: e1329693. PMID 28868344 DOI: 10.1080/23723556.2017.1329693  0.718
2017 Chawanthayatham S, Valentine CC, Fedeles BI, Fox EJ, Loeb LA, Levine SS, Slocum SL, Wogan GN, Croy RG, Essigmann JM. Mutational spectra of aflatoxin B1 in vivo establish biomarkers of exposure for human hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 28351974 DOI: 10.1073/Pnas.1700759114  0.792
2017 Wang C, Gong G, Sheh A, Muthupalani S, Bryant EM, Puglisi DA, Holcombe H, Conaway EA, Parry NA, Bakthavatchalu V, Short SP, Williams CS, Wogan GN, Tannenbaum SR, Fox JG, et al. Interleukin-22 drives nitric oxide-dependent DNA damage and dysplasia in a murine model of colitis-associated cancer. Mucosal Immunology. PMID 28198364 DOI: 10.1038/Mi.2017.9  0.357
2017 Chawanthayatham S, Valentine CC, Fedeles BI, Slocum SL, Wogan GN, Croy RG, Essigmann JM. Abstract LB-229: Mutation spectra of aflatoxin B1invivoestablish biomarkers of exposure for human hepatocellualr carcinoma Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-229  0.792
2015 Techapiesancharoenkij N, Fiala JL, Navasumrit P, Croy RG, Wogan GN, Groopman JD, Ruchirawat M, Essigmann JM. Sulforaphane, a cancer chemopreventive agent, induces pathways associated with membrane biosynthesis in response to tissue damage by aflatoxin B1. Toxicology and Applied Pharmacology. 282: 52-60. PMID 25450479 DOI: 10.1016/J.Taap.2014.11.004  0.765
2015 Chao MW, Erkekoglu P, Tseng CY, Ye W, Trudel LJ, Skipper PL, Tannenbaum SR, Wogan GN. Protective effects of ascorbic acid against the genetic and epigenetic alterations induced by 3,5-dimethylaminophenol in AA8 cells. Journal of Applied Toxicology : Jat. 35: 466-77. PMID 25178734 DOI: 10.1002/Jat.3046  0.329
2015 Chawanthayatham S, Thiantanawat A, Egner PA, Groopman JD, Wogan GN, Croy RG, Essigmann JM. Prenatal exposure of mice to the human liver carcinogen aflatoxin B1 reveals a critical window of susceptibility to genetic change. International Journal of Cancer. Journal International Du Cancer. 136: 1254-62. PMID 25070670 DOI: 10.1002/Ijc.29102  0.769
2014 Erkekoglu P, Chao MW, Ye W, Ge J, Trudel LJ, Skipper PL, Kocer-Gumusel B, Engelward BP, Wogan GN, Tannenbaum SR. Cytoplasmic and nuclear toxicity of 3,5-dimethylaminophenol and potential protection by selenocompounds. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 72: 98-110. PMID 25014158 DOI: 10.1016/J.Fct.2014.06.031  0.302
2014 Chao MW, Erkekoglu P, Tseng CY, Ye W, Trudel LJ, Skipper PL, Tannenbaum SR, Wogan GN. Intracellular generation of ROS by 3,5-dimethylaminophenol: persistence, cellular response, and impact of molecular toxicity. Toxicological Sciences : An Official Journal of the Society of Toxicology. 141: 300-13. PMID 24973092 DOI: 10.1093/Toxsci/Kfu127  0.337
2014 Turowski EE, Belanger CL, Trudel LJ, Wogan GN, Parry NM, Fox JG. Tu1743 DNA Mutation Spectra in a Mouse Model of Colitis Progressing to Neoplasia Gastroenterology. 146: S-831. DOI: 10.1016/S0016-5085(14)63019-5  0.354
2013 Mangerich A, Dedon PC, Fox JG, Tannenbaum SR, Wogan GN. Chemistry meets biology in colitis-associated carcinogenesis. Free Radical Research. 47: 958-86. PMID 23926919 DOI: 10.3109/10715762.2013.832239  0.305
2013 Gong G, Muthupalani S, Wogan GN, Fox JG, Tannenbaum SR. Abstract A17: Colitis-associated tumorigenesis in the Rag2 -/- Helicobacter hepaticus-infected mouse features DNA damage and Retinoblastoma-mediated cell proliferation via nitric oxide but not hypochlorous acid Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-A17  0.359
2012 Wogan GN, Dedon PC, Tannenbaum SR, Fox JG. Infection, inflammation and colon carcinogenesis. Oncotarget. 3: 737-8. PMID 22964519 DOI: 10.18632/Oncotarget.624  0.34
2012 Chao MW, Kim MY, Ye W, Ge J, Trudel LJ, Belanger CL, Skipper PL, Engelward BP, Tannenbaum SR, Wogan GN. Genotoxicity of 2,6- and 3,5-dimethylaniline in cultured mammalian cells: the role of reactive oxygen species. Toxicological Sciences : An Official Journal of the Society of Toxicology. 130: 48-59. PMID 22831970 DOI: 10.1093/Toxsci/Kfs229  0.358
2012 Wattanawaraporn R, Kim MY, Adams J, Trudel LJ, Woo LL, Croy RG, Essigmann JM, Wogan GN. AFB(1) -induced mutagenesis of the gpt gene in AS52 cells. Environmental and Molecular Mutagenesis. 53: 567-73. PMID 22733615 DOI: 10.1002/Em.21711  0.703
2012 Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, Prestwich E, Cui L, McFaline JL, Mobley M, Ge Z, Taghizadeh K, Wishnok JS, Wogan GN, Fox JG, Tannenbaum SR, et al. Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: E1820-9. PMID 22689960 DOI: 10.1073/Pnas.1207829109  0.386
2012 Wattanawaraporn R, Woo LL, Belanger C, Chang SC, Adams JE, Trudel LJ, Bouhenguel JT, Egner PA, Groopman JD, Croy RG, Essigmann JM, Wogan GN. A single neonatal exposure to aflatoxin b1 induces prolonged genetic damage in two loci of mouse liver. Toxicological Sciences : An Official Journal of the Society of Toxicology. 128: 326-33. PMID 22539618 DOI: 10.1093/Toxsci/Kfs151  0.763
2012 Kim MY, Lim CH, Trudel LJ, Deen WM, Wogan GN. Delivery method, target gene structure, and growth properties of target cells impact mutagenic responses to reactive nitrogen and oxygen species. Chemical Research in Toxicology. 25: 873-83. PMID 22303861 DOI: 10.1021/Tx2004882  0.32
2012 Wogan GN, Kensler TW, Groopman JD. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Additives & Contaminants. Part a, Chemistry, Analysis, Control, Exposure & Risk Assessment. 29: 249-57. PMID 21623489 DOI: 10.1080/19440049.2011.563370  0.682
2011 Woo LL, Egner PA, Belanger CL, Wattanawaraporn R, Trudel LJ, Croy RG, Groopman JD, Essigmann JM, Wogan GN, Bouhenguel JT. Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice. Toxicological Sciences : An Official Journal of the Society of Toxicology. 122: 38-44. PMID 21507988 DOI: 10.1093/Toxsci/Kfr087  0.758
2011 Fiala JL, Egner PA, Wiriyachan N, Ruchirawat M, Kensler KH, Wogan GN, Groopman JD, Croy RG, Essigmann JM. Sulforaphane-mediated reduction of aflatoxin B₁-N⁷-guanine in rat liver DNA: impacts of strain and sex. Toxicological Sciences : An Official Journal of the Society of Toxicology. 121: 57-62. PMID 21278056 DOI: 10.1093/Toxsci/Kfr026  0.773
2011 Kensler TW, Roebuck BD, Wogan GN, Groopman JD. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicological Sciences : An Official Journal of the Society of Toxicology. 120: S28-48. PMID 20881231 DOI: 10.1093/Toxsci/Kfq283  0.645
2011 Groopman JD, Wogan GN. Aflatoxin and hepatocellular carcinoma Current Cancer Research. 6: 113-133. DOI: 10.1007/978-1-61737-995-6_6  0.408
2010 Skipper PL, Kim MY, Sun HL, Wogan GN, Tannenbaum SR. Monocyclic aromatic amines as potential human carcinogens: old is new again. Carcinogenesis. 31: 50-8. PMID 19887514 DOI: 10.1093/Carcin/Bgp267  0.371
2010 Sheh A, Lee C, Masumura K, Rickman BH, Nohmi T, Wogan GN, Fox JG, Schauer D. T1181 Helicobacter pylori Infection Induces Gastric Mutations in Mice: Influence of Gender and Duration of Infection Gastroenterology. 138: S-506. DOI: 10.1016/S0016-5085(10)62336-0  0.325
2007 Kim MY, Zhou X, Delaney JC, Taghizadeh K, Dedon PC, Essigmann JM, Wogan GN. AlkB influences the chloroacetaldehyde-induced mutation spectra and toxicity in the pSP189 supF shuttle vector. Chemical Research in Toxicology. 20: 1075-83. PMID 17658757 DOI: 10.1021/Tx700167V  0.695
2007 Wogan GN. Does perinatal antiretroviral therapy create an iatrogenic cancer risk? Environmental and Molecular Mutagenesis. 48: 210-4. PMID 17358028 DOI: 10.1002/Em.20283  0.308
2007 Zayas B, Stillwell SW, Wishnok JS, Trudel LJ, Skipper P, Yu MC, Tannenbaum SR, Wogan GN. Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients. Carcinogenesis. 28: 342-9. PMID 16926175 DOI: 10.1093/Carcin/Bgl142  0.403
2006 Kim MY, Wogan GN. Mutagenesis of the supF gene of pSP189 replicating in AD293 cells cocultivated with activated macrophages: roles of nitric oxide and reactive oxygen species. Chemical Research in Toxicology. 19: 1483-91. PMID 17112236 DOI: 10.1021/Tx0601354  0.313
2006 Jang HG, Park M, Wishnok JS, Tannenbaum SR, Wogan GN. Hydroxyl-specific fluorescence labeling of ABP-deoxyguanosine, PhIP-deoxyguanosine, and AFB1-formamidopyrimidine with BODIPY-FL. Analytical Biochemistry. 359: 151-60. PMID 17081492 DOI: 10.1016/J.Ab.2006.08.030  0.358
2006 Skipper PL, Trudel LJ, Kensler TW, Groopman JD, Egner PA, Liberman RG, Wogan GN, Tannenbaum SR. DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice. Chemical Research in Toxicology. 19: 1086-90. PMID 16918249 DOI: 10.1021/Tx060082Q  0.694
2006 Li CQ, Pang B, Kiziltepe T, Trudel LJ, Engelward BP, Dedon PC, Wogan GN. Threshold effects of nitric oxide-induced toxicity and cellular responses in wild-type and p53-null human lymphoblastoid cells. Chemical Research in Toxicology. 19: 399-406. PMID 16544944 DOI: 10.1021/Tx050283E  0.356
2005 Li CQ, Wright TL, Dong M, Dommels YE, Trudel LJ, Dedon PC, Tannenbaum SR, Wogan GN. Biological role of glutathione in nitric oxide-induced toxicity in cell culture and animal models. Free Radical Biology & Medicine. 39: 1489-98. PMID 16274884 DOI: 10.1016/J.Freeradbiomed.2005.07.011  0.338
2005 Li CQ, Wogan GN. Nitric oxide as a modulator of apoptosis. Cancer Letters. 226: 1-15. PMID 16004928 DOI: 10.1016/J.Canlet.2004.10.021  0.311
2005 Kim MY, Dong M, Dedon PC, Wogan GN. Effects of peroxynitrite dose and dose rate on DNA damage and mutation in the supF shuttle vector. Chemical Research in Toxicology. 18: 76-86. PMID 15651852 DOI: 10.1021/Tx049777M  0.394
2004 Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Seminars in Cancer Biology. 14: 473-86. PMID 15489140 DOI: 10.1016/J.Semcancer.2004.06.010  0.426
2004 Liu Z, Hergenhahn M, Schmeiser HH, Wogan GN, Hong A, Hollstein M. Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene. Proceedings of the National Academy of Sciences of the United States of America. 101: 2963-8. PMID 14976251 DOI: 10.1073/Pnas.0308607101  0.34
2003 Wang C, Trudel LJ, Wogan GN, Deen WM. Thresholds of nitric oxide-mediated toxicity in human lymphoblastoid cells. Chemical Research in Toxicology. 16: 1004-13. PMID 12924928 DOI: 10.1021/Tx0340448  0.303
2003 Pamir B, Wogan GN. Carbon dioxide modulation of peroxynitrite-induced mutagenesis of the supF gene in pSP189. Chemical Research in Toxicology. 16: 487-92. PMID 12703965 DOI: 10.1021/Tx020093T  0.344
2002 Li CQ, Trudel LJ, Wogan GN. Genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells exposed to peroxynitrite generated from SIN-1. Chemical Research in Toxicology. 15: 527-35. PMID 11952339 DOI: 10.1021/Tx010171X  0.306
2000 Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, Hofseth LJ, Shields PG, Billiar TR, Trautwein C, Hohler T, Galle PR, Phillips DH, Markin R, Marrogi AJ, et al. Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proceedings of the National Academy of Sciences of the United States of America. 97: 12770-5. PMID 11050162 DOI: 10.1073/Pnas.220416097  0.359
2000 Wogan GN. Impacts of chemicals on liver cancer risk. Seminars in Cancer Biology. 10: 201-10. PMID 10936069 DOI: 10.1006/Scbi.2000.0320  0.385
2000 Fu P, Von Tungeln LS, Hammons GJ, McMahon G, Wogan G, Flammang TJ, Kadlubar FF. Metabolic activation capacity of neonatal mice in relation to the neonatal mouse tumorigenicity bioassay Drug Metabolism Reviews. 32: 241-266. PMID 10774778 DOI: 10.1081/Dmr-100100575  0.344
2000 Tretyakova NY, Burney S, Pamir B, Wishnok JS, Dedon PC, Wogan GN, Tannenbaum SR. Peroxynitrite-induced DNA damage in the supF gene: correlation with the mutational spectrum. Mutation Research. 447: 287-303. PMID 10751613 DOI: 10.1016/S0027-5107(99)00221-3  0.406
2000 Zhuang JC, Wright TL, deRojas-Walker T, Tannenbaum SR, Wogan GN. Nitric oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium. Environmental and Molecular Mutagenesis. 35: 39-47. PMID 10692226 DOI: 10.1002/(Sici)1098-2280(2000)35:1<39::Aid-Em6>3.0.Co;2-H  0.345
2000 Moshinsky DJ, Wogan GN. UV-induced mutagenesis of human p53: analysis using a double-selection method in yeast. Environmental and Molecular Mutagenesis. 35: 31-8. PMID 10692225 DOI: 10.1002/(Sici)1098-2280(2000)35:1<31::Aid-Em5>3.0.Co;2-S  0.321
1999 Kensler TW, Tsuda H, Wogan GN. United States-Japan workshop on New Rodent Models for the Analysis and Prevention of Carcinogenesis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 8: 1033-7. PMID 10566560  0.413
1998 Nair J, Gal A, Tamir S, Tannenbaum SR, Wogan GN, Bartsch H. Etheno adducts in spleen DNA of SJL mice stimulated to overproduce nitric oxide. Carcinogenesis. 19: 2081-4. PMID 9886560 DOI: 10.1093/Carcin/19.12.2081  0.368
1998 Zhuang JC, Lin C, Lin D, Wogan GN. Mutagenesis associated with nitric oxide production in macrophages. Proceedings of the National Academy of Sciences of the United States of America. 95: 8286-91. PMID 9653179 DOI: 10.1073/Pnas.95.14.8286  0.32
1998 Jeong JK, Juedes MJ, Wogan GN. Mutations induced in the supF gene of pSP189 by hydroxyl radical and singlet oxygen: relevance to peroxynitrite mutagenesis. Chemical Research in Toxicology. 11: 550-6. PMID 9585487 DOI: 10.1021/Tx980008A  0.323
1997 Kobertz WR, Wang D, Wogan GN, Essigmann JM. An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot. Proceedings of the National Academy of Sciences of the United States of America. 94: 9579-84. PMID 9275165 DOI: 10.1073/Pnas.94.18.9579  0.791
1997 Moshinsky DJ, Wogan GN. UV-induced mutagenesis of human p53 in a vector replicated in Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences of the United States of America. 94: 2266-71. PMID 9122183 DOI: 10.1073/Pnas.94.6.2266  0.357
1996 NEWBERNE PM, WOGAN GN, CARLTON WW, ABDELKADER MM. HISTOPATHOLOGIC LESIONS IN DUCKLINGS CAUSED BY ASPERGILLUS FLAVUS CULTURES, CULTURE EXTRACTS, AND CRYSTALLINE AFLATOXINS. Toxicology and Applied Pharmacology. 6: 542-56. PMID 14216995 DOI: 10.1016/0041-008X(64)90086-9  0.337
1996 CHANG SB, ABDEL-KADER MM, WICK EL, WOGAN GN. AFLATOXIN B2: CHEMICAL IDENTITY AND BIOLOGICAL ACTIVITY. Science (New York, N.Y.). 142: 1191-2. PMID 14072177 DOI: 10.1126/Science.142.3596.1191  0.359
1996 Gal A, Wogan GN. Mutagenesis associated with nitric oxide production in transgenic SJL mice. Proceedings of the National Academy of Sciences of the United States of America. 93: 15102-7. PMID 8986771 DOI: 10.1073/Pnas.93.26.15102  0.31
1996 Kensler TW, Groopman JD, Wogan GN. Use of carcinogen-DNA and carcinogen-protein adduct biomarkers for cohort selection and as modifiable end points in chemoprevention trials. Iarc Scientific Publications. 237-48. PMID 8923034  0.629
1996 Wang JS, Busby WF, Wogan GN. Percutaneous absorption and tissue distribution of [3H]diacetoxyscirpenol (anguidine) in rats and mice. Toxicology and Applied Pharmacology. 140: 264-73. PMID 8887442 DOI: 10.1006/Taap.1996.0221  0.3
1996 Juedes MJ, Wogan GN. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutation Research. 349: 51-61. PMID 8569792 DOI: 10.1016/0027-5107(95)00152-2  0.323
1995 Wang JS, Busby WF, Wogan GN. Tissue distribution of DNA adducts in pre-weanling BLU:Ha mice treated with a tumorigenic dose of fluoranthene. Cancer Letters. 92: 9-19. PMID 7757965 DOI: 10.1016/0304-3835(95)03751-H  0.397
1995 Wang JS, Busby WF, Wogan GN. Formation and persistence of DNA adducts in organs of CD-1 mice treated with a tumorigenic dose of fluoranthene. Carcinogenesis. 16: 2609-16. PMID 7586175 DOI: 10.1093/Carcin/16.11.2609  0.352
1994 Groopman JD, Wogan GN, Roebuck BD, Kensler TW. Molecular biomarkers for aflatoxins and their application to human cancer prevention. Cancer Research. 54: 1907s-1911s. PMID 8137310  0.622
1994 Sheabar FZ, Morningstar ML, Wogan GN. Adduct detection by acylation with [35S]methionine: analysis of DNA adducts of 4-aminobiphenyl. Proceedings of the National Academy of Sciences of the United States of America. 91: 1696-700. PMID 8127867 DOI: 10.1073/Pnas.91.5.1696  0.377
1994 Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 3: 3-10. PMID 8118382  0.497
1994 Sheabar FZ, Morningstar ML, Wogan GN. Peracylation of nucleosides with methionine: foundation for a method to detect carcinogen adducts. Chemical Research in Toxicology. 7: 650-8. PMID 7841344 DOI: 10.1021/Tx00041A010  0.351
1993 Sheabar FZ, Groopman JD, Qian GS, Wogan GN. Quantitative analysis of aflatoxin-albumin adducts. Carcinogenesis. 14: 1203-8. PMID 8508508 DOI: 10.1093/Carcin/14.6.1203  0.545
1993 Larson PS, McMahon G, Wogan GN. Modulation of c-myc gene expression in rat livers by aflatoxin B1 exposure and age. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 20: 316-24. PMID 8504905 DOI: 10.1006/Faat.1993.1041  0.347
1993 Oleykowski CA, Mayernik JA, Lim SE, Groopman JD, Grossman L, Wogan GN, Yeung AT. Repair of aflatoxin B1 DNA adducts by the UvrABC endonuclease of Escherichia coli. The Journal of Biological Chemistry. 268: 7990-8002. PMID 8463319  0.554
1993 Soman NR, Wogan GN. Activation of the c-Ki-ras oncogene in aflatoxin B1-induced hepatocellular carcinoma and adenoma in the rat: detection by denaturing gradient gel electrophoresis. Proceedings of the National Academy of Sciences of the United States of America. 90: 2045-9. PMID 8446626 DOI: 10.1073/Pnas.90.5.2045  0.382
1993 Groopman JD, Wild CP, Hasler J, Junshi C, Wogan GN, Kensler TW. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. Environmental Health Perspectives. 99: 107-13. PMID 8319607 DOI: 10.1289/Ehp.9399107  0.658
1992 Groopman JD, Hasler JA, Trudel LJ, Pikul A, Donahue PR, Wogan GN. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography. Cancer Research. 52: 267-74. PMID 1728400  0.525
1992 Groopman JD, Zhu JQ, Donahue PR, Pikul A, Zhang LS, Chen JS, Wogan GN. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Research. 52: 45-52. PMID 1727385  0.512
1992 Wogan GN. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research. Environmental Health Perspectives. 98: 167-78. PMID 1486846 DOI: 10.1289/Ehp.9298167  0.378
1992 Ross RK, Yu MC, Henderson BE, Yuan JM, Qian GS, Tu JT, Gao YT, Wogan GN, Groopman JD. Aflatoxin biomarkers. Lancet (London, England). 340: 119. PMID 1351989  0.408
1992 Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet (London, England). 339: 943-6. PMID 1348796 DOI: 10.1016/0140-6736(92)91528-G  0.586
1992 Wild CP, Hudson GJ, Sabbioni G, Chapot B, Hall AJ, Wogan GN, Whittle H, Montesano R, Groopman JD. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1: 229-34. PMID 1339083  0.483
1992 Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan GN, Montesano R, Wild CP. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1: 221-7. PMID 1339082  0.529
1990 McMahon G, Huber LJ, Moore MJ, Stegeman JJ, Wogan GN. Mutations in c-Ki-ras oncogenes in diseased livers of winter flounder from Boston Harbor. Proceedings of the National Academy of Sciences of the United States of America. 87: 841-5. PMID 2405390 DOI: 10.1073/Pnas.87.2.841  0.432
1990 Wang JS, Busby WF, Wogan GN. Comparative tissue distribution and excretion of orally administered [3H]diacetoxyscirpenol (anguidine) in rats and mice. Toxicology and Applied Pharmacology. 103: 430-40. PMID 2339416 DOI: 10.1016/0041-008X(90)90316-M  0.312
1990 Sabbioni G, Ambs S, Wogan GN, Groopman JD. The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. Carcinogenesis. 11: 2063-6. PMID 2121383 DOI: 10.1093/Carcin/11.11.2063  0.585
1990 McMahon G, Davis EF, Huber LJ, Kim Y, Wogan GN. Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors. Proceedings of the National Academy of Sciences of the United States of America. 87: 1104-8. PMID 2105496 DOI: 10.1073/Pnas.87.3.1104  0.369
1989 Gorelick NJ, Hutchins DA, Tannenbaum SR, Wogan GN. Formation of DNA and hemoglobin adducts of fluoranthene after single and multiple exposures Carcinogenesis. 10: 1579-1587. PMID 2670302 DOI: 10.1093/Carcin/10.9.1579  0.432
1989 Gorelick NJ, Wogan GN. Fluoranthene-DNA adducts: Identification and quantification by an HPLC-32P-postlabelling method Carcinogenesis. 10: 1567-1577. PMID 2670301 DOI: 10.1093/Carcin/10.9.1567  0.396
1989 Wogan GN. Markers of exposure to carcinogens. Environmental Health Perspectives. 81: 9-17. PMID 2667991 DOI: 10.1289/Ehp.89819  0.383
1989 Wogan GN. Markers of exposure to carcinogens: Methods for human biomonitoring Journal of the American College of Toxicology. 8: 871-881. DOI: 10.3109/10915818909018048  0.377
1989 Wogan GN. Molecular and cellular events associated with aflatoxin-induced hepatocarcinogenesis Pure and Applied Chemistry. 61: 1-6. DOI: 10.1351/Pac198961010001  0.481
1988 Gan LS, Skipper PL, Peng XC, Groopman JD, Chen JS, Wogan GN, Tannenbaum SR. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis. 9: 1323-5. PMID 3133131 DOI: 10.1093/Carcin/9.7.1323  0.533
1988 McMahon G, Huber LJ, Stegeman JJ, Wogan GN. Identification of a c-Ki-ras oncogene in a neoplasm isolated from winter flounder Marine Environmental Research. 24: 345-350. DOI: 10.1016/0141-1136(88)90333-9  0.35
1987 McMahon G, Davis E, Wogan GN. Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors Proceedings of the National Academy of Sciences of the United States of America. 84: 4974-4978. PMID 3110778 DOI: 10.1073/Pnas.84.14.4974  0.349
1987 Miller MS, Kono M, Wogan GN. N-methyl-n'-nitro-n-nitrosoguanidine and benzo[a]pyrene-7,8-diol-9,10-epoxide inhibit glucocorticoid-inducible polyoma virus middle-t gene expression in rat mt-1 cells by a post-transcriptional mechanism Carcinogenesis. 8: 1159-1163. PMID 3038361 DOI: 10.1093/Carcin/8.8.1159  0.32
1986 Babson JR, Russo-Rodriguez SE, Wattley RV, Bergstein PL, Rastetter WH, Liber HL, Andon BM, Thilly WG, Wogan GN. Microsomal activation of fluoranthene to mutagenic metabolites. Toxicology and Applied Pharmacology. 85: 355-66. PMID 3764921 DOI: 10.1016/0041-008X(86)90343-1  0.353
1986 Wogan GN, McMahon G. Intragenomic localization of carcinogen-DNA damage Basic Life Sciences. 38: 127-134. PMID 3741326 DOI: 10.1007/978-1-4615-9462-8_13  0.393
1986 Babson JR, Russo-Rodriguez SE, Rastetter WH, Wogan GN. In vitro DNA-binding of microsomally-activated fluoranthene: evidence that the major product is a fluoranthene N2-deoxyguanosine adduct. Carcinogenesis. 7: 859-65. PMID 3708750 DOI: 10.1093/Carcin/7.6.859  0.386
1985 Irvin TR, Wogan GN. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA Cancer Research. 45: 3497-3502. PMID 3926300  0.318
1984 Groopman JD, Trudel LJ, Donahue PR, Marshak-Rothstein A, Wogan GN. High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays Proceedings of the National Academy of Sciences of the United States of America. 81: 7728-7731. PMID 6440143 DOI: 10.1073/Pnas.81.24.7728  0.559
1984 Irvin TR, Wogan GN. Quantitation of aflatoxin B1 addition within the ribosomal RNA gene sequences of rat liver DNA Proceedings of the National Academy of Sciences of the United States of America. 81: 664-668. PMID 6422462  0.317
1983 Essigmann JM, Green CL, Croy RG, Fowler KW, Büchi GH, Wogan GN. Interactions of aflatoxin B1 and alkylating agents with DNA: structural and functional studies. Cold Spring Harbor Symposia On Quantitative Biology. 47: 327-37. PMID 6407800 DOI: 10.1101/Sqb.1983.047.01.038  0.786
1983 Croy RG, Essigmann JM, Wogan GN. Aflatoxin B1: correlations of patterns of metabolism and DNA modification with biological effects. Basic Life Sciences. 24: 49-62. PMID 6407467 DOI: 10.1007/978-1-4684-4400-1_3  0.717
1983 Nordheim A, Hao WM, Wogan GN, Rich A. Salt-induced conversion of B-DNA to Z-DNA inhibited by aflatoxin B1 Science. 219: 1434-1436. PMID 6402818 DOI: 10.1126/Science.6402818  0.387
1982 Essigmann JM, Croy RG, Bennett RA, Wogan GN. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. Drug Metabolism Reviews. 13: 581-602. PMID 6813091 DOI: 10.3109/03602538209011088  0.772
1982 Groopman JD, Haugen A, Goodrich GR, Wogan GN, Harris CC. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies. Cancer Research. 42: 3120-4. PMID 6807538  0.556
1982 Groopman JD, Croy RG, Wogan GN. In vitro reactions of aflatoxin B1-adducted DNA Proceedings of the National Academy of Sciences of the United States of America. 78: 5445-5449. PMID 6795633 DOI: 10.1073/Pnas.78.9.5445  0.581
1982 Imamura T, Busby WF, Goldman ME, Wogan GN, Brunengraber H. Effects of hydroxyurea and benzo(a)pyrene on DNA synthesis in the isolated perfused rat lung Bulletin of Environmental Contamination and Toxicology. 28: 135-140. PMID 6279214 DOI: 10.1007/Bf01608565  0.366
1981 Croy RG, Wogan GN. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1 Cancer Research. 41: 197-203. PMID 7448760  0.36
1981 Groopman JD, Fowler KW, Busby WF, Wogan GN. Short communication: Interaction of aflatoxin b2 with rat liver dna and histones in vivo Carcinogenesis. 2: 1371-1373. PMID 7326836 DOI: 10.1093/Carcin/2.12.1371  0.604
1981 Croy RG, Wogan GN. Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys Journal of the National Cancer Institute. 66: 761-768. PMID 6939922  0.33
1981 Haugen A, Groopman JD, Hsu IC, Goodrich GR, Wogan GN, Harris CC. Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Proceedings of the National Academy of Sciences of the United States of America. 78: 4124-7. PMID 6794029 DOI: 10.1073/Pnas.78.7.4124  0.598
1981 Bennett RA, Essigmann JM, Wogan GN. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats. Cancer Research. 41: 650-4. PMID 6778611  0.709
1981 Croy RG, Wogan GN. Quantitative Comparison of Formed in Rat and Mouse Covalent Aflatoxin-DNA Livers and Kidneys Journal of the National Cancer Institute. 66: 761-768. DOI: 10.1093/Jnci/66.4.761  0.44
1980 Croy RG, Nixon JE, Sinnhuber RO, Wogan GN. Investigation of covalent aflatoxin B1-DNA adducts formed in vivo in rainbow trout (Salmo gairdneri) embryos and liver Carcinogenesis. 1: 903-909. PMID 11219843  0.32
1980 Groopman JD, Busby WF, Wogan GN. Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo Cancer Research. 40: 4343-4351. PMID 7438068  0.497
1980 Pezzuto JM, Lau PP, Luh Y, Moore PD, Wogan GN, Hecht SM. There is a correlation between the DNA affinity and mutagenicity of several 3-amino-1-methyl-5H-pyrido[4,3-b]indoles Proceedings of the National Academy of Sciences of the United States of America. 77: 1427-1431. PMID 6990411 DOI: 10.1073/Pnas.77.3.1427  0.37
1980 Essigmann JM, Donahue PR, Story DL, Wogan GN, Brunengraber H. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin. Cancer Research. 40: 4085-91. PMID 6781740  0.717
1979 Autrup H, Essigmann JM, Croy RG, Trump BF, Wogan GN, Harris CC. Metabolism of aflatoxin B1 and identification of the major aflatoxin B1-DNA adducts formed in cultured human bronchus and colon. Cancer Research. 39: 694-8. PMID 427755  0.715
1979 Stark AA, Essigmann JM, Demain AL, Skopek TR, Wogan GN. Aflatoxin B1 mutagenesis, DNA binding, and adduct formation in Salmonella typhimurium. Proceedings of the National Academy of Sciences of the United States of America. 76: 1343-7. PMID 375236 DOI: 10.1073/Pnas.76.3.1343  0.719
1979 Essigmann JM, Barker LJ, Fowler KW, Francisco MA, Reinhold VN, Wogan GN. Sterigmatocystin-DNA interactions: identification of a major adduct formed after metabolic activation in vitro. Proceedings of the National Academy of Sciences of the United States of America. 76: 179-83. PMID 284330 DOI: 10.1073/Pnas.76.1.179  0.728
1978 Roebuck BD, Siegel WG, Wogan GN. In vitro metabolism of aflatoxin B2 by animal and human liver Cancer Research. 38: 999-1002. PMID 639051  0.301
1978 Stark AA, Kobbe B, Matsuo D, Büchi G, Wogan GN, Demain AL. Mollicellins: mutagenic and antibacterial mycotoxins. Applied and Environmental Microbiology. 36: 412-20. PMID 365106 DOI: 10.1128/Aem.36.3.412-420.1978  0.673
1978 Croy RG, Essigmann JM, Reinhold VN, Wogan GN. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. Proceedings of the National Academy of Sciences of the United States of America. 75: 1745-9. PMID 273905 DOI: 10.1073/Pnas.75.4.1745  0.744
1978 Croy RG, Essigmann JM, Reinhold VN, Wogan GN. Identification of the principal aflatoxin B1 DNA adduct formed in vivo in rat liver Proceedings of the American Association For Cancer Research. No. 761.  0.721
1977 Essigmann JM, Busby WF, Wogan GN. Quantitative determination of transfer RNA base composition using high-pressure liquid chromatography. Analytical Biochemistry. 81: 384-94. PMID 907101 DOI: 10.1016/0003-2697(77)90709-6  0.669
1977 Rosiello AP, Essigmann JM, Wogan GN. Rapid and accurate determination of the median lethal dose (Ld50) and its error with a small computer Journal of Toxicology and Environmental Health. 3: 797-809. PMID 599579 DOI: 10.1080/15287397709529614  0.643
1977 Essigmann JM, Croy RG, Nadzan AM, Busby WF, Reinhold VN, Büchi G, Wogan GN. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proceedings of the National Academy of Sciences of the United States of America. 74: 1870-4. PMID 266709 DOI: 10.1073/Pnas.74.5.1870  0.809
1976 Kensler TW, Busby WF, Davidson NE, Wogan GN. Effect of hepatocarcinogens on the binding of glucocorticoid receptor complex in rat liver nuclei Cancer Research. 36: 4647-4651. PMID 1000507  0.483
1976 Kensler TW, Busby WF, Davidson NE, Wogan GN. Aflatoxin inhibition of glucocorticoid binding capacity of rat liver nuclei Bba - General Subjects. 437: 200-210. PMID 181075 DOI: 10.1016/0304-4165(76)90361-5  0.518
1975 Busby WF, Hurley PM, Wogan GN. Acute effects of aflatoxin B1 on tRNA methylase function Life Sciences. 17: 519-522. PMID 1186419 DOI: 10.1016/0024-3205(75)90084-3  0.32
1975 Glinsukon T, Shank RC, Wogan GN. Effects of cytochalasin E on fluid balance in the rat Toxicology and Applied Pharmacology. 32: 158-167. PMID 1135871 DOI: 10.1016/0041-008X(75)90206-9  0.508
1975 Glinsukon T, Shank RC, Wogan GN, Newberne PM. Acute and subacute toxicity of cytochalasin E in the rat Toxicology and Applied Pharmacology. 32: 135-146. PMID 1135869 DOI: 10.1016/0041-008X(75)90204-5  0.527
1974 Wogan GN, Paglialunga S, Newberne PM. Carcinogenic effects of low dietary levels of aflatoxin B1 in rats Food and Cosmetics Toxicology. 12: 681-685. PMID 4375655 DOI: 10.1016/0015-6264(74)90239-9  0.346
1974 Wogan GN, Paglialunga S. Carcinogenicity of synthetic aflatoxin M1 in rats Food and Cosmetics Toxicology. 12: 381-384. PMID 4374416 DOI: 10.1016/0015-6264(74)90012-1  0.338
1974 Büchi GH, Müller PM, Roebuck BD, Wogan GN. Aflatoxin Q1: a major metabolite of aflatoxin B1 produced by human liver. Research Communications in Chemical Pathology and Pharmacology. 8: 585-92. PMID 4214448  0.692
1974 Glinsukon T, Yuan S, Wightman R, Kitaura Y, BÜchi G, Shank R, Wogan G, Christensen C. Isolation and Purification of Cytochalasin E and Two Tremorgens from Aspergillus Clavatus Plant Foods For Man. 1: 113-119. DOI: 10.1080/03062686.1974.11904162  0.406
1974 Thilly WG, Nowak TS, Wogan GN. Maintaining perpetual synchrony in HeLa S3 culture Biotechnology and Bioengineering. 16: 149-156. DOI: 10.1002/Bit.260160111  0.315
1973 Büchi G, Kitaura Y, Yuan SS, Wright HE, Clardy J, Demain AL, Ginsukon T, Hunt N, Wogan GN. Letter: structure of cytochalasin E, a toxic metabolite of Aspergillus clavatus. Journal of the American Chemical Society. 95: 5423-5. PMID 4733808 DOI: 10.1021/Ja00797A060  0.637
1973 Buchi G, Spitzner D, Paglialunga S, Wogan GN. Synthesis and toxicity evaluation of aflatoxin P. Life Sciences. 13: 1143-9. PMID 4357691 DOI: 10.1016/0024-3205(73)90381-0  0.684
1972 Shank RC, Siddhichai P, Subhamani B, Bhamarapravati N, Gordon JE, Wogan GN. Dietary aflatoxins and human liver cancer. V. Duration of primary liver cancer and prevalence of hepatomegaly in Thailand Food and Cosmetics Toxicology. 10: 181-191. PMID 5072819 DOI: 10.1016/S0015-6264(72)80196-2  0.485
1972 Shank RC, Bhamarapravati N, Gordon JE, Wogan GN. Dietary aflatoxins and human liver cancer. IV. Incidence of primary liver cancer in two municipal populations of Thailand Food and Cosmetics Toxicology. 10: 171-179. PMID 5072818 DOI: 10.1016/S0015-6264(72)80195-0  0.472
1972 Edwards GS, Wogan GN. Ribonuclease activity in liver nuclei of aflatoxin-treated rats. Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology. 11: 685-9. PMID 4656877 DOI: 10.1016/0024-3205(72)90051-3  0.359
1972 Shank RC, Gordon JE, Wogan GN, Nondasuta A, Subhamani B. Dietary aflatoxins and human liver cancer. III. Field survey of rural Thai families for ingested aflatoxins Food and Cosmetics Toxicology. 10: 71-84. DOI: 10.1016/S0015-6264(72)80048-8  0.479
1972 Shank RC, Wogan GN, Gibson JB, Nondasuta A. Dietary aflatoxins and human liver cancer. II. Aflatoxins in market foods and foodstuffs of Thailand and Hong Kong Food and Cosmetics Toxicology. 10: 61-69. DOI: 10.1016/S0015-6264(72)80047-6  0.444
1972 Shank RC, Wogan GN, Gibson JB. Dietary aflatoxins and human liver cancer. I. Toxigenic moulds in foods and foodstuffs of tropical south-east asia Food and Cosmetics Toxicology. 10: 51-60. DOI: 10.1016/S0015-6264(72)80046-4  0.47
1971 Akao M, Kuroda K, Wogan GN. Aflatoxin B1: the kidney as a site of action in the mouse. Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology. 10: 495-501. PMID 5580480 DOI: 10.1016/0024-3205(71)90123-8  0.312
1971 Büchi G, Klaubert DH, Shank RC, Weinreb SM, Wogan GN. Structure and synthesis of kotanin and desmethylkotanin, metabolites of Aspergillus glaucus. The Journal of Organic Chemistry. 36: 1143-7. PMID 5551701  0.7
1971 Pong RS, Wogan GN. Toxicity and biochemical and fine structural effects of synthetic aflatoxins M 1 and B 1 in rat liver. Journal of the National Cancer Institute. 47: 585-92. PMID 5157578 DOI: 10.1093/Jnci/47.3.585  0.373
1971 Wogan GN, Edwards GS, Newberne PM. Acute and chronic toxicity of rubratoxin B. Toxicology and Applied Pharmacology. 19: 712-20. PMID 5132038 DOI: 10.1016/0041-008X(71)90303-6  0.338
1971 Dalezios J, Wogan GN, Weinreb SM. Aflatoxin P-1: a new aflatoxin metabolite in monkeys. Science (New York, N.Y.). 171: 584-5. PMID 4992832 DOI: 10.1126/Science.171.3971.584  0.346
1971 BUECHI G, KLAUBERT DH, SHANK RC, WEINREB SM, WOGAN GN. ChemInform Abstract: STRUKTUR UND SYNTH. VON KOTANIN UND DESMETHYLKOTANIN, METABOLITEN VON ASPERGILLUS GLAUCUS Chemischer Informationsdienst. Organische Chemie. 2: no-no. DOI: 10.1002/chin.197131329  0.394
1970 Edwards GS, Wogan GN. Aflatoxin inhibition of template activity of rat liver chromatin. Biochimica Et Biophysica Acta. 224: 597-607. PMID 5498089 DOI: 10.1016/0005-2787(70)90591-5  0.382
1970 Pong RS, Wogan GN. Inhibition by aflatoxin B1 of rat liver zoxazolamine hydroxylase induction. Biochemical Pharmacology. 19: 2808-12. PMID 5478589 DOI: 10.1016/0006-2952(70)90109-7  0.381
1970 Friedman MA, Wogan GN. Liver nuclear RNA metabolism in rats treated with aflatoxin B1. Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology. 9: 741-7. PMID 5478087 DOI: 10.1016/0024-3205(70)90290-0  0.349
1969 Pong RS, Wogan GN. Time course of alterations of rat liver polysome profiles induced by aflatoxin B 1 . Biochemical Pharmacology. 18: 2357-61. PMID 5403974 DOI: 10.1016/0006-2952(69)90350-5  0.368
1968 Wogan GN, Friedman MA. Inhibition by aflatonin B-1 of hydrocortisone induction of rat liver tryptophan pyrrolase and tyrosine transaminase. Archives of Biochemistry and Biophysics. 128: 509-16. PMID 4386974 DOI: 10.1016/0003-9861(68)90058-1  0.387
1967 Newberne PM, Russo R, Wogan GN. Acute toxicity of aflatoxin B1 in the dog. Pathologia Veterinaria. 3: 331-40. PMID 5957330 DOI: 10.1177/030098586600300403  0.316
1967 Gelboin HV, Wortham JS, Wilson RG, Friedman M, Wogan GN. Rapid and marked inhibition of rat-liver RNA polymerase by aflatoxin B-1. Science (New York, N.Y.). 154: 1205-6. PMID 5921386 DOI: 10.1126/Science.154.3753.1205  0.368
1966 Sporn MB, Wesley Dingman C, Phelps HL, Wogan GN. Aflatoxin Bi: Binding to DNA in vitro and alteration of RNA metabolism in vivo Science. 151: 1539-1541. PMID 5909585 DOI: 10.1126/Science.151.3717.1539  0.394
1966 Shank RC, Wogan GN. Acute effects of aflatoxin B1 on liver composition and metabolism in the rat and duckling Toxicology and Applied Pharmacology. 9: 468-476. DOI: 10.1016/0041-008X(66)90006-8  0.585
1963 Asao T, Buchi G, Abdel-Kader MM, Chang SB, Wick EL, Wogan GN. Aflatoxins B and G Journal of the American Chemical Society. 85: 1706-1707. DOI: 10.1021/Ja00894A050  0.682
Show low-probability matches.